Lexaria Bioscience Corp. Stock Price - LXRP

Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Lexaria Bioscience Corp. (QX) LXRP Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00816 1.06% 0.77816 0.8088 0.74 0.77 0.77 10:32:13
Bid Price Ask Price Spread Spread % News
0.771 0.8263 0.0553 6.69% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
17 10,818 $ 0.777359 $ 8,409 73,404 0.60 - 2.24
Last Trade Time Type Quantity Stock Price Currency
10:29:12 2,500 $ 0.77816 USD

Lexaria Bioscience Corp. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 60.63M 78.64M $ -6.60M - - 62.93M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
156.52k $ - 0.00% - -

more financials information »

Lexaria Bioscience Corp. News

Loading Messages....

Latest LXRP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LXRP Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week0.860.940.740.818485k-0.08184-9.52%
1 Month0.734910.60.776181k0.043265.89%
3 Months0.97921.030.60.818074k-0.20104-20.53%
6 Months1.481.530.61.014693k-0.70184-47.42%
1 Year1.8752.240.61.4188158k-1.09684-58.50%
3 Years0.1482.540.111.0957219k0.63016425.78%
5 Years0.132.540.040.8735173k0.64816498.58%

Lexaria Bioscience Corp. Description

Lexaria Bioscience Corp. has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds. Lexaria has multiple patents pending and granted in over 40 countries around the world and was granted its first patent in the USA in October. 2016. Lexaria's technology provides increases of up to 1Ox in intestinal absorption rates; more rapid delivery to the bloodstream with effects often with in 15-20 minutes; and important taste-masking benefits for orally administered bioactive molecules including but not limited to cannabinoids, vitamins, NSAIDs, and nicotine.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.